First-Line Treatment After Perioperative FLOT in Recurrent Gastric and Gastroesophageal Junction Cancer: A Turkish Oncology Group (TOG) Multicenter Real-World Analysis.

Medicina (Kaunas) · 2026 · PMC13208910 · PMID 42195237

Europe PMC DOI

hedged sentences

0.1380

closest p · 2.8× alpha

0.1380

boldest claim

The sentences

showed a trendp = 0.138not close (p > 0.1)

HER2 positivity showed a trend toward improved OS on multivariable analysis (HR 0.68, 95% CI 0.40–1.13; p = 0.138), though this did not retain statistical significance, likely due to the limited number of HER2-positive patients (n = 23).

also in 53,322 other papers

did not reach statistical significanceno p-value reported

Although the ChT+Trastuzumab group demonstrated numerically longer PFS and OS, this did not reach statistical significance, likely reflecting the limited sample size of this subgroup.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.